Literature DB >> 12849869

Lectin and serum-PSA interaction as a screening test for prostate cancer.

Pranab S Basu1, Ramdhan Majhi, Sandip K Batabyal.   

Abstract

OBJECTIVES: The present investigation was designed to distinguish prostate cancer and benign prostate hyperplasia by lectin-prostate specific antigen (PSA) binding. DESIGN AND METHODS: The quantitative precipitin method of concanavalin A (Con A)-carbohydrate interaction was explored with the serum PSA of patients suffering from prostatic complications.
RESULTS: The carbohydrate content in the precipitate after binding of Con A with serum PSA of prostate cancer was significantly lower than that of benign prostate hyperplasia. This may be due to altered sugar chain structure or less glycosylation of PSA in prostate cancer.
CONCLUSIONS: We conclude that a serum value <3.0 microg/ml of the carbohydrate content of Con A-PSA precipitate indicates strong suspicion for prostate cancer and this cut off level is effective in reducing the rate of unnecessary biopsies in men with total PSA value between 4.0 to 10.0 ng/ml.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849869     DOI: 10.1016/s0009-9120(03)00050-x

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  Probing mucin-type O-linked glycosylation in living animals.

Authors:  Danielle H Dube; Jennifer A Prescher; Chi N Quang; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

Review 2.  Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer.

Authors:  Jan Tkac; Veronika Gajdosova; Stefania Hroncekova; Tomas Bertok; Michal Hires; Eduard Jane; Lenka Lorencova; Peter Kasak
Journal:  Interface Focus       Date:  2019-02-15       Impact factor: 3.906

3.  Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples.

Authors:  Mark Stovsky; Lee Ponsky; Srinivas Vourganti; Peter Stuhldreher; Mike B Siroky; Victor Kipnis; Olga Fedotoff; Larissa Mikheeva; Boris Zaslavsky; Arnon Chait; J Stephen Jones
Journal:  Urology       Date:  2011-07-23       Impact factor: 2.649

4.  Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.

Authors:  Zhiqun Tang; Rency S Varghese; Slavka Bekesova; Christopher A Loffredo; Mohamed Abdul Hamid; Zuzana Kyselova; Yehia Mechref; Milos V Novotny; Radoslav Goldman; Habtom W Ressom
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

5.  Lectin-based estimation of glycated hemoglobin in diabetes mellitus.

Authors:  Pranab S Basu; Sudip Chatterji; Sandip K Batabyal
Journal:  J Clin Lab Anal       Date:  2012-01       Impact factor: 2.352

6.  Comparison of the methods for profiling N-glycans-hepatocellular carcinoma serum glycomics study.

Authors:  Ran Wang; Yufei Liu; Chang Wang; Henghui Li; Xin Liu; Liming Cheng; Yanhong Zhou
Journal:  RSC Adv       Date:  2018-07-20       Impact factor: 3.361

Review 7.  Plant Lectins as Medical Tools against Digestive System Cancers.

Authors:  Laura Elena Estrada-Martínez; Ulisses Moreno-Celis; Ricardo Cervantes-Jiménez; Roberto Augusto Ferriz-Martínez; Alejandro Blanco-Labra; Teresa García-Gasca
Journal:  Int J Mol Sci       Date:  2017-07-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.